Abstract:Objective: To analyze the value of multiparameter magnetic resonance (mpMRI) in the diagnosis of pancreatic cancer with vascular invasion from two aspects: morphology and function, so as to provide a reliable diagnostic basis for preparing the clinical treatment plans. Methods: Totally 31 case data of pancreatic cancer patients diagnosed in our hospital from January 2020 to March 2021 were enrolled in this study. All patients underwent multiparameter magnetic resonance imaging (T1WI, T2WI, DKI, and DCE-MRI) before surgery, and then all patients underwent pancreatic cancer surgery. Two experienced radiologists analyzed these obtained images according to the image reports and combined them with the pathological results. Taking pathological results as gold standard, the sensitivity, specificity, and accuracy of quantitative parameters derived from T2WI, DKI, DCE, T2WI + DKI, T2WI + DCE, and T2WI + DKI + DCE for the diagnostic capabilities of pancreatic cancer vascular invasion were calculated using diagnostic laboratory methods. Kappa consistency test was used to estimate the consistency of two radiologists' diagnosis and analysis. The images obtained by DKI sequence were input into the postprocessing software MITK-Diffusion v2014.10.02, The images obtained from DCE sequence were processed by the Tissue 4D software on the Siemens syngo via workstation to calculate and analyze each tumor ROI's MD, MK values from DKI, and K trans, K ep, V e values from DCE. Independent samples t-test was used to compare the parameters of pancreatic cancer with vascular invasion group (16 cases) and nonvascular invasion group (15 cases). ROC curve was used to analyze the efficacy of each parameter in diagnosing pancreatic cancer vascular invasion. Results: The sensitivity, specificity, and accuracy of T2WI were 62.5%, 53.5%, and 58.1%; those of DKI were 56.3%, 60.0%, and 58.1%; those of DCE were 68.8%, 60.0%, and 64.5%; those of T2WI + DKI were 68.8%, 66.7%, and 67.7%; those of T2WI + DCE were 75.0%, 66.7%, and 71.1%; those of T2WI + DKI + DCE were 81.2%, 73.3%, and 77.4%, respectively. These two diagnostic radiologists analyzed image data with good consistency, Kappa = 0.834. MD, MK, K trans, K ep, and V e were significantly different between the vascular invasion group and the nonvascular invasion group (p < 0.05). Each parameter's AUC of ROC curve was 0.773, 0.829, 0.794, 0.802, and 0.846 (p < 0.05). Take MD = 2.285 × 10-3 mm/s2, MK = 0.72, K trans = 0.103, K ep = 0.337, and V e = 0.353 as thresholds; the sensitivity of these parameters to diagnose vascular invasion of pancreatic cancer was 73.33%, 75%, 87.5%, 68.8%, and 68.8%. The specificity of them was 75%, 80%, 60%, 86.7%, and 86.7%, respectively. Conclusion: The combined analysis of T2WI + DKI + DCE can improve the specificity and accuracy of diagnostic efficiency of vascular invasion of pancreatic cancer and provide an important diagnostic basis for pancreatic cancer's preoperative treatment.

Pancreatic Mass Characterization Using IVIM-DKI MRI and Machine Learning-Based Multi-Parametric Texture Analysis

Value of Texture Analysis of Intravoxel Incoherent Motion Parameters in Differential Diagnosis of Pancreatic Neuroendocrine Tumor and Pancreatic Adenocarcinoma

Evaluation of Texture Analysis for the Differential Diagnosis of Mass-Forming Pancreatitis From Pancreatic Ductal Adenocarcinoma on Contrast-Enhanced CT Images

Predictive Value of the Texture Analysis of Enhanced Computed Tomographic Images for Preoperative Pancreatic Carcinoma Differentiation.

Multiparametric Mapping Magnetic Resonance Imaging of Pancreatic Disease

MRI Texture Analysis for Differentiating Nonfunctional Pancreatic Neuroendocrine Neoplasms from Solid Pseudopapillary Neoplasms of the Pancreas.

Analysis of IVIM Perfusion Fraction Improves Detection of Pancreatic Ductal Adenocarcinoma

Diagnostic Accuracy of Unenhanced CT Texture Analysis to Differentiate Mass-Forming Pancreatitis from Pancreatic Ductal Adenocarcinoma

Multimodel Magnetic Resonance Imaging of Mass-Forming Autoimmune Pancreatitis: Differential Diagnosis with Pancreatic Ductal Adenocarcinoma

The Diagnostic Value of Intravoxel Incoherent Motion Diffusion-Weighted Imaging for Distinguishing Nonhypervascular Pancreatic Neuroendocrine Tumors from Pancreatic Ductal Adenocarcinomas.

Intra voxel Incoherent Motion Diffusion-weighted Imaging Quantitative Parameters in Evaluating Differentiated Degrees of Pancreatic Cancer

Differential Diagnosis of Nonhypervascular Pancreatic Neuroendocrine Neoplasms from Pancreatic Ductal Adenocarcinomas, Based on Computed Tomography Radiological Features and Texture Analysis.

Intravoxel incoherent motion and diffusion kurtosis imaging and their machine‐learning‐based texture analysis for detection and assessment of prostate cancer severity at 3 T

Differentiation of Pancreas Carcinoma from Healthy Pancreas Using Diffusion-Weighted MR Imaging:Comparison of Apparent Diffusion Coefficient and Intravoxel Incoherent Motion-Derived Parameters

The Added Value of Intravoxel Incoherent Motion Diffusion Weighted Imaging Parameters in Differentiating High-Grade Pancreatic Neuroendocrine Neoplasms from Pancreatic Ductal Adenocarcinoma

Differentiation of Pancreatic Carcinoma and Mass-Forming Focal Pancreatitis: Qualitative and Quantitative Assessment by Dynamic Contrast-Enhanced MRI Combined with Diffusion-Weighted Imaging

Differentiation of Atypical Pancreatic Neuroendocrine Tumors from Pancreatic Ductal Adenocarcinomas: Using Whole-Tumor CT Texture Analysis As Quantitative Biomarkers

Quantitative Parameters of Intravoxel Incoherent Motion Diffusion Weighted Imaging (IVIM-DWI): Potential Application in Predicting Pathological Grades of Pancreatic Ductal Adenocarcinoma.

Multiparameter Magnetic Resonance Quantitative Evaluation of Pancreatic Cancer with Vascular Invasion

Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions

Development and Validation of a Novel Model Incorporating MRI-based Radiomics Signature with Clinical Biomarkers for Distinguishing Pancreatic Carcinoma from Mass-Forming Chronic Pancreatitis.